Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics ...

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) ...

"Zymeworks reports Phase I data for ZW191 ADC" was originally created and published by Clinical Trials Arena, a GlobalData ...

The data, first presented at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting, showed that the phase 3 ...

Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Confirmed responses observed in eight tumor types spanning ova ...

Investing.com -- PMV Pharmaceuticals Inc (NASDAQ:PMVP) stock rose 2.2% on Friday after the company reported encouraging clinical trial results for its cancer drug rezatapopt, showing responses across ...

PMV Pharmaceuticals (PMVP) announced updated data from the Phase 2 pivotal portion of the ongoing PYNNACLE clinical trial. Results were presented ...

There are three different methods of performing a hysterectomy, depending on the reason for it and the size of the uterus. Abdominal: The most common method, which involves a 6in cut across the lower ...

A newly developed antibody which restricts the growth of treatment-resistant breast cancers offers new hope for patients. It ...

I obviously had all of the relevant organs removed, but it came back a couple times in a lymph node,” the 67-year-old ...

Christiane Amanpour is fighting ovarian cancer for a second time in a "fairly rare" form, but added that the returning cancer ...